Marine anticancer drug works by novel mechanism

A sea squirt extract is showing considerable promise in the treatment of a number of types of bone and soft-tissue cancers.

Written bySusan Aldridge
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Ecteinascidin 743 (Et743) is a compound derived from a Caribbean sea squirt (Ecteinascidia turbinate) and is currently showing great promise against advanced soft-tissue and bone sarcomas in clinical trials. In July 2001 Nature Medicine, Yuji Takebayashi and colleagues at the US National Cancer Institute (NCI) and the Institute for Cancer Research, Japan reveal that Et743 represents a new class of anti-cancer drug, which works by subverting one of the cell's normal mechanisms of DNA repair (Nature Med 2001, 7:961-966).

While DNA repair is desirable in healthy cells, the aim when treating cancers is to cause as much DNA damage as possible to malignant cells. Any drug that undermines DNA repair in cancer cells enhances this damage – and leads to the speedy death of the cell.

Like a number of other anticancer drugs — for example, mustine and cyclophosphamide — Et743 is an alkylating agent. What sets it apart the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo
Discover how to streamline tumor-infiltrating lymphocyte production.

Producing Tumor-infiltrating Lymphocyte Therapeutics

cytiva logo

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery